Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes)

Brain Research

Volumn 1245, Issue , 2008, Pages 16-25

  Harrison, Laura M ^a   LaHoste, Gerald J ^b   Ruskin, David N ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

Caudate putamen; Dopamine; In situ hybridization; mRNA; Nucleus accumbens

Indexed keywords

DOPAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROTEIN RHES; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CELL NUCLEUS; CEREBELLUM; CORPUS STRIATUM; DENTATE GYRUS; GENE; HIPPOCAMPUS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONTOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RHES GENE; SIGNAL DETECTION; WESTERN BLOTTING;

ADRENERGIC AGENTS; AMINO ACID SEQUENCE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; CEREBELLUM; DENTATE GYRUS; DOPAMINE; GENE EXPRESSION; GTP-BINDING PROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTIONS, INTRAVENTRICULAR; NEURONS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS;

EID: 56049110190     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.09.066     Document Type: Article

References (53)

1. 3H] spiroperidol binding autoradiographs. J. Neurosci. Meth. 10 (1984) 173-188
2. Avale M.E., Falzone T.L., Gelman D.M., Low M.J., Grandy D.K., and Rubenstein M. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder. Mol. Psychiatry 9 (2004) 718-726
3. Breese G.R., Knapp D.J., Criswell H.E., Moy S.S., Papadeas S.T., and Blake B.L. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res. Rev. 48 (2005) 57-73
4. Bruno J.P., Sandstrom M.I., Arnold H.M., and Nelson C.L. Age-dependent neurobehavioral plasticity following forebrain dopamine depletions. Dev. Neurosci. 20 (1998) 164-179
5. Caboche J., Rogard M., and Besson M.J. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution. Dev. Brain Res. 58 (1991) 111-122
6. Cali J.J., Balcueva E.A., Rybalkin I., and Robishaw J.D. Selective tissue distribution of G protein γ subunits, including a new form of the γ subunits identified by cDNA cloning. J. Biol. Chem. 267 (1992) 24023-24027
7. 2 dopamine receptor mRNA in rat corpus striatum. Dev. Brain Res. 63 (1991) 95-104
8. Cheng H.-Y.M., Obrietan K., Cain S.W., Lee B.Y., Agostino P.V., Joza N.A., Harrington M.E., Ralph M.R., and Penninger J.M. Dexras1 potentiates photic and suppresses nonphotic responses of the circadian clock. Neuron 43 (2004) 715-728
9. 1-like receptor not coupled to adenylyl cyclase. Neuroscience 93 (1999) 1483-1489
10. Duncan G.E., Breese G.R., Criswell H.E., Johnson K.B., Schambra U.B., Mueller R.A., Caron M.G., and Fremeau R.T. D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development. J. Neurochem. 61 (1993) 1255-1262
11. Ehrlich M.E., Kurihara T., and Greengard P. Rat DARPP-32: cloning, sequencing, and characterization of the cDNA. J. Mol. Neurosci. 2 (1990) 1-10
12. Ehrlich M.E., Rosen N.L., Kurihara T., Shalaby I.A., and Greengard P. DARPP-32 development in the caudate nucleus is independent of afferent input from the substantia nigra. Dev. Brain Res. 54 (1990) 257-263
13. Errico F., Santini E., Migliarini S., Borgkvist A., Centonze D., Nasti V., Carta M., De Chiara V., Prosperetti C., Spano D., Herve D., Pasqualetti M., Di Lauro R., Fisone G., and Usiello A. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Mol. Cell. Neurosci. 37 (2008) 335-345
14. Falk J.D., Vargiu P., Foye P.E., Usui H., Perez J., Danielson P.E., Lerner D.L., Bernal J., and Sutcliffe J.G. Rhes: a striatal-specific ras homolog related to Dexras1. J. Neurosci. Res. 57 (1999) 782-788
15. Fang M., Jaffrey S.R., Sawa A., Ye K., Luo X., and Snyder S.H. Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON. Neuron 28 (2000) 183-193
16. Glatt C.E., and Snyder S.H. Cloning and expression of adenylyl cyclase localized to the corpus striatum. Nature 361 (1993) 536-538
17. i-coupled formyl peptide receptor to Erk-1/2 MAP kinases. J. Biol. Chem. 277 (2002) 10876-10882
18. 2 dopamine receptor gene expression in the rat striatum during ontogeny: an in situ hybridization study. Dev. Brain Res. 60 (1991) 79-87
19. Harrison L.M., and LaHoste G.J. Rhes, the ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Neuroscience 137 (2006) 483-492
20. 1 receptor with adenylyl cyclase. J. Neurosci. 13 (1993) 2237-2248
21. Joyce J.N., Loeschen S.K., and Marshall J.F. Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation. Brain Res. 338 (1985) 209-218
22. Joyce J.N., Frohna P.A., and Neal-Beliveau B.S. Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci. Biobehav. Rev. 20 (1996) 453-486
23. Kim D.S., Szczypka M.S., and Palmiter R.D. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J. Neurosci. 20 (2000) 4405-4413
24. Kim D.S., Froelick G.J., and Palmiter R.D. Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum. J. Neurosci. 22 (2002) 9841-9849
25. Leslie C.A., Robertson M.W., Cutler A.J., and Bennett J.P. Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis. Dev. Brain Res. 62 (1991) 109-114
26. Lombroso P.J., Naegele J.R., Sharma E., and Lerner M. A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures. J. Neurosci. 13 (1993) 3064-3074
27. Luthman J., Lindqvist E., Young D., and Cowburn R. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity. Exp. Brain Res. 83 (1990) 85-95
28. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10 (1990) 2587-2600
29. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46 (1992) 959-971
30. Marshall J.F., Navarrete R., and Joyce J.N. Decreased striatal binding density following mesotelencephalic 6-hydroxydopamine injections: an autoradiographic analysis. Brain Res. 493 (1989) 247-257
31. 2 receptor in the rat brain by in situ hybridization histochemistry. Proc. Natl. Acad. Sci. USA 86 (1989) 8560-8564
32. Noriyama Y., Ogawa Y., Yoshino H., Yamashita M., and Kishimoto T. Dopamine profoundly suppresses excitatory transmission in neonatal rat hippocampus via phosphatidylinositol-linked D1-like receptor. Neuroscience 138 (2006) 475-485
33. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, New York
34. Polli J.W., Billingsley M.L., and Kincaid R.L. Expression of the calmodulin-dependent protein phosphatase, calcineurin, in rat brain: developmental patterns and the role of nigrostriatal innervation. Dev. Brain Res. 63 (1991) 105-119
35. Polli J.W., Kincaid R.L., Torris J., and Billingsley M.L. Expression of calmodulin-dependent enzymes in developing rat striatum is not affected by perturbation of dopaminergic systems. Synapse 9 (1991) 136-143
36. Quintero, G.C., Spano, D., LaHoste, G.J., Harrison, L.M., 2008. The ras homolog rhes affects dopamine D1 and D2 receptor-mediated behavior in mice. NeuroReport 19, 1563-1566.
37. Rahman Z., Gold S.J., Potenza M.N., Cowan C.W., Ni Y.G., He W., Wensel T.G., and Nestler E.J. Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J Neurosci. 19 (1999) 2016-2026
38. Raisman-Vozari R., Girault J.A., Moussaoui S., Feuerstein C., Jenner P., Marsden C.D., and Agid Y. Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. Brain Res. 507 (1990) 45-50
39. Rao P.A., Molinoff P.B., and Joyce J.N. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev. Brain Res. 60 (1991) 161-177
40. 3H]SCH 23390. Brain Res. 375 (1986) 291-301
41. 2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding. Neuroscience 62 (1994) 65-85
42. Spano D., Branchi I., Roscia A., Pirro M.T., Riccio A., Mithbaokar P., Affuso A., Arra C., Campolongo P., Terracciano D., Macchia V., Bernal J., Alleva E., and Di Lauro R. Rhes is involved in striatal function. Mol. Cell. Biol. 24 (2004) 5788-5796
43. 2 receptor mRNA in rat brain. Eur. J. Pharmacol. 225 (1992) 143-150
44. Szele F.G., Artymyshyn R., Molinoff P.B., and Chesselet M.F. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry. Anat. Rec. 231 (1991) 548-558
45. Takesono A., Nowak M.W., Cismowski M., Duzic E., and Lanier S.M. Activator of G-protein signaling 1 blocks GIRK channel activation by a G-protein-coupled receptor: apparent disruption of receptor signaling complexes. J. Biol. Chem. 277 (2002) 13827-13830
46. Thomas E.A., Danielson P.E., and Sutcliffe J.G. RGS9: a regulator of G-protein signaling with specific expression in rat and mouse striatum. J. Neurosci. Res. 52 (1998) 118-124
47. Thomas W.S., Neal-Beliveau B.S., and Joyce J.N. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum. Dev Brain Res. 111 (1998) 99-106
48. Usui H., Falk J.D., Dopazo A., de Lecea L., Erlander M.G., and Sutcliffe J.G. Isolation of clones of rat striatum-specific mRNAs by directional tag PCR subtraction. J. Neurosci. 14 (1994) 4915-4926
49. Vallortigara J., Alfos S., Micheau J., Higueret P., and Enderlin V. T3 administration in adult hypothyroid mice modulates expression of proteins involved in striatal synaptic plasticity and improves motor behavior. Neurobiol. Dis. 31 (2008) 378-385
50. Vargiu P., Morte B., Manzano J., Perez J., de Abajo R., Sutcliffe J.G., and Bernal J. Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum. Mol. Brain Res. 94 (2001) 1-8
51. Vargiu P., De Abajo R., Garcia-Ranea J.A., Valencia A., Santisteban P., Crespo P., and Bernal J. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 23 (2004) 559-568
52. Walaas S.I., Aswad D.W., and Greengard P. A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301 (1983) 69-71
53. Watson J.B., Coulter P.M., Margulies J.E., de Lecea L., Danielson P.E., Erlander M.G., and Sutcliff J.G. G protein gamma 7 subunit is selectively expressed in medium-sized neurons and dendrites of the rat neostriatum. J. Neurosci. Res. 39 (1994) 108-116